Increased risk of type I errors for detecting heterogeneity of treatment effects in cluster-randomized trials using mixed-effect models
Noorie Hyun, Abisola E. Idu, Andrea J. Cook, Jennifer F. Bobb

TL;DR
This study reveals that standard mixed-effect models often produce inflated false-positive rates when detecting heterogeneity of treatment effects in cluster-randomized trials, especially if they assume uniform within-cluster correlations.
Contribution
It demonstrates that flexible GLMMs accounting for subgroup-specific correlations improve inference accuracy in HTE analyses for CRTs.
Findings
Standard GLMMs can have up to 47.2% type 1 error rate.
Flexible GLMMs maintain nominal error rates across scenarios.
Model specification significantly affects real-world HTE inference.
Abstract
Evaluating heterogeneity of treatment effects (HTE) across subgroups is common in both randomized trials and observational studies. Although several statistical challenges of HTE analyses including low statistical power and multiple comparisons are widely acknowledged, issues arising for clustered data, including cluster randomized trials (CRTs), have received less attention. Notably, the potential for model misspecification is increased given the complex clustering structure (e.g., due to correlation among individuals within a subgroup and cluster), which could impact inference and type 1 errors. To illicit this issue, we conducted a simulation study to evaluate the performance of common analytic approaches for testing the presence of HTE for continuous, binary, and count outcomes: generalized linear mixed models (GLMM) and generalized estimating equations (GEE) including interaction…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Statistical Methods in Clinical Trials · Health Systems, Economic Evaluations, Quality of Life
